Editor's Picks (Total records: loading...)
Drug Manufacturers
Bristol-Myers Squibb Co (BMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Cost Savings
Bristol-Myers Squibb Co (BMY) reports robust revenue growth and outlines strategic cost-saving initiatives amid challenges from generic competition and market dynamics. Feb 07, 2025
Medical Devices & Instruments
Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Business Separation
Becton Dickinson & Co (BDX) reports robust financial performance with 9.6% revenue growth and announces plans to unlock value through business separation. Feb 07, 2025